A Phase (ph) 0/ia Study of Brigimadlin Concentration in Brain Tissue and a Non-Randomized, Open-Label, Dose Escalation Study of Brigimadlin in Combination with Radiotherapy (RT) in Patients (pts) with Newly Diagnosed Glioblastoma (GBM).
NEURO-ONCOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined